Ruud van der Breggen

Leiden University Medical Center

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Leiden University Medical Center

Research Subjects

Research Interests

Ruud van der Breggen has a total of 60 co-authors. Here are the top co-authors by number of shared publications:

Marieke E. Ijsselsteijn
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
46 shared publications
Noel F. C. C. de Miranda
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
45 shared publications
Manon van der Ploeg
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
44 shared publications
Dina Ruano
Department of Pathology, Leiden University Medical Center
41 shared publications
Elisabeth M. E. Verdegaal
Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands
41 shared publications
Jitske van Den Bulk
Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands
41 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Expression of tumor associated antigens in early and later metastatic lesions.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S6 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Expression of tumor associated antigens in early and later metastatic lesions.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class I genotypes as determined by exome and transcriptome sequencing.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S3 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class I genotypes as determined by exome and transcriptome sequencing.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Whole-exome sequencing strategy.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Whole-exome sequencing strategy.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class I and II expression on melanoma cell lines derived from early and later metastatic lesions.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S2 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class I and II expression on melanoma cell lines derived from early and later metastatic lesions.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Methods S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
More detailed information on: 1) Immune-fluorescent staining, 2) Mass spectrometry, 3) MLTC and TIL cultures.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Methods S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
More detailed information on: 1) Immune-fluorescent staining, 2) Mass spectrometry, 3) MLTC and TIL cultures.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Putative neoantigens in early and later metastatic lesions.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S5 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Putative neoantigens in early and later metastatic lesions.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Eluted tumor-associated antigen-derived peptides.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Table S5 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Eluted tumor-associated antigen-derived peptides.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Immunohistochemical staining of proteins involved in T cell recognition and/or inhibition.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S1 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
Immunohistochemical staining of proteins involved in T cell recognition and/or inhibition.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
T cell recognition of melanoma cell lines derived from early and later metastatic lesions.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S3 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
T cell recognition of melanoma cell lines derived from early and later metastatic lesions.
Open Access
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class II expression and recognition of early and later metastatic lesion- derived tumor cells from patient Mel5 by CD4+ and CD8⁺ T cells.
Website
Google Scholar
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Supplementary Figure S4 from Neoantigen Targetability in Progressive Advanced Melanoma
by Jitske van Den Bulk, Els M.E. Verdegaal, Manon van der Ploeg, Marten Visser, Joana B. Nunes, Arnoud H. de Ru, Rayman T.N. Tjokrodirijo, Marieke E. Ijsselsteijn, Natasja I. Janssen, Ruud van der Breggen, et al.
HLA class II expression and recognition of early and later metastatic lesion- derived tumor cells from patient Mel5 by CD4+ and CD8⁺ T cells.

Show all